The Goodyear Tire & Rubber Company GT shares are trading flat premarket on Wednesday. On Tuesday, the company entered a deal to sell its Dunlop brand to Sumitomo Rubber Industries (SRI) for cash proceeds of around $701 million.
The purchase amount covers the brand transfer across Europe, North America, and Oceania, a transition support fee, and Dunlop tire inventory purchase.
The deal also includes ongoing offtake, licensing, and other commercial arrangements.
Dunlop brand includes trademarks and related intangible assets for consumer, commercial, and specialty tires across Europe, North America, and Oceania.
As per the deal, Goodyear will continue producing and distributing Dunlop consumer tires in Europe until at least December 31, 2025, paying royalties to SRI while retaining all profits.
The agreement automatically extends through December 31, 2026, unless mutually terminated earlier, giving SRI time to scale its operations.
Post-TLA, Goodyear will supply SRI with a minimum of 4.5 million Dunlop tires annually for five years under the Transition Offtake Agreement, with SRI able to terminate after three years, subject to a fee. Goodyear will earn a markup on each tire sold.
Goodyear will also retain rights to the Dunlop motorcycle tire brand in Europe and Oceania and license back Dunlop trademarks for commercial tires in Europe.
The transaction, expected to close by mid-2025, is subject to regulatory approvals, customary closing conditions, and consultations.
Goodyear plans to use the proceeds to reduce debt and support initiatives under its Goodyear Forward transformation plan.
The transaction is expected to reduce Goodyear’s segment operating income by $65 million annually during the TOA, excluding benefits from debt repayment and other initiatives.
Investors can gain exposure to the stock via Invesco S&P Midcap 400 Pure Value ETF RFV.
Price Action: GT shares were up 0.23% at $8.85 premarket at the last check Wednesday.
Read Next:
Photo via Shutterstock.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.